H.R. 7980
IntroducedProtecting Americans from Unsafe Drugs Act of 2026
Plain-language analysis
Not yet analyzed.
A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text below and the official source are the record.
Full text of the bill
Official source on Congress.gov ↗[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7980 Introduced in House (IH)]
<DOC>
119th CONGRESS 2d Session H. R. 7980
To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 18, 2026
Ms. Dexter introduced the following bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Protecting Americans from Unsafe Drugs Act of 2026''.
SEC. 2. NOTIFICATION, NONDISTRIBUTION, AND RECALL OF DRUGS.
(a) Order To Cease Distribution and Recall.--Section 569D of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-8d) is amended--
(1) in the section heading, by striking ``controlled substances'' and inserting ``drugs'';
(2) by striking ``controlled substance'' each place such term appears and inserting ``drug'';
(3) in subsection (b)--
(A) by striking ``controlled substances'' and inserting ``drugs''; and
(B) by inserting ``of subsection (a)'' after ``an order pursuant to paragraph (1) or an amended order pursuant to subparagraph (B) or (C) of paragraph (3)''; and
(4) in subsection (c), by striking ``or an official senior to such Director'' and inserting ``or the Director of the Center for Biologics Evaluation and Research (or an official senior to either such Director)''.
(b) Imports and Exports.--Section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended by striking ``is a controlled substance subject to an order under section 569D'' and inserting ``is a drug subject to an order under section 569D''. <all>